15-min delayed · Sep 8, 3:45 PM ET · Get real-time quotes →
The Quantellect read.Of the 2 firms covering Precigen Inc, 2 rate it Buy or better, 0 sit at Hold, and 0 rate it Sell or worse, a strong buy consensus. Targets span $11.00 to $18.00, a moderate spread. The average target of $14.50 sits 111% above the current $6.86. The rating mix has stayed broadly stable, with Buy-side ratings easing from 3 to 2 over recent months. On the fundamentals, the Street sees consensus EPS building from about $0.11 next quarter toward $0.68 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS2 ratings
Strong Buy
Strong Buy00%
Buy2100%
Hold00%
Sell00%
Strong Sell00%
Based on 2 analysts giving stock ratings to Precigen Inc.
As of Sep, 2 of 2 firms rate PGEN a Buy (0 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
PGEN EPS & revenue forecast
EPS · NEXT QUARTER
$0.11
Range $0.06 – $0.21 · 3 analysts · -1199% YoY
Next period, 3 analysts expect Precigen Inc to earn $0.11 a share (range $0.06 – $0.21), versus $-0.01 a year earlier. Full-year consensus is $0.22, growing to $0.68 the year after.
REVENUE · NEXT QUARTER
$85.5M
Range $66.4M – $120.0M · 3 analysts · +1774% YoY
Revenue is expected to reach $85.5M (range $66.4M – $120.0M), +1773.6% year-over-year. Full-year consensus is $233.0M, rising to $454.4M next year.
Top analysts covering Precigen Inc
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on PGEN.
#1
Jason Butler
JMP Securities · Rank #31
Buy
$11.00+60.3% to target
Overall win rate
53%
+ Follow
#2
Swayampakula Ramakanth
HC Wainwright & Co. · Rank #252
Buy
$18.00+162.4% to target
Overall win rate
38%
+ Follow
#3
JN
Jason N. Butler
Citizens
Buy
$11.00+60.3% to target
Coverage
—
+ Follow
#4
JK
Jennifer Kim
Cantor Fitzgerald
Buy
No targeton PGEN
Coverage
—
+ Follow
#5
Brian Cheng
JP Morgan
Hold
No targeton PGEN
Coverage
—
+ Follow
PGEN stock forecast FAQ
What is PGEN's average 12-month price target?+
The 2 analysts with a live target average $14.50 for Precigen Inc over the next 12 months, ranging from a $18.00 high to a $11.00 low.
Is PGEN stock a Buy, Sell or Hold right now?+
The current consensus is Strong Buy. Of the 2 analyst ratings, 2 are Buy or Strong Buy, 0 are Hold, and 0 are Sell or Strong Sell.
What are the highest and lowest price targets for PGEN?+
The Street-high target is $18.00 (HC Wainwright & Co.), and the Street-low is $11.00 (Citizens). The average of all 2 active targets is $14.50.
How many Wall Street analysts cover PGEN?+
2 analysts have an active rating on Precigen Inc, and 2 firms carry a live 12-month price target.
Who is the most accurate analyst covering PGEN?+
Among analysts who currently cover PGEN, Jason Butler of JMP Securities has the strongest overall Quantellect track record (Rank #31). Their current call is Buy with a $11.00 target.
What is Precigen Inc's projected EPS for next quarter?+
The consensus estimate is $0.11 per share (range $0.06 – $0.21) across 3 analysts. Full-year EPS is projected at $0.22, rising to $0.68 the following year.
How much revenue is Precigen Inc expected to report next quarter?+
Consensus revenue is $85.5M (range $66.4M – $120.0M). Full-year revenue is projected at $233.0M, growing to $454.4M next year.
Have analysts been upgrading or downgrading PGEN lately?+
As of Sep, 2 of 2 firms rate PGEN a Buy (0 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their PGEN calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.
